This Healthcare Stock Jumps Around 188%, Here’s 83 Biggest Movers From Yesterday
Gainers
Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.
Why Is NeuroSense Therapeutics Surging by 70%? 46 Stocks Moving In Monday’s Mid-Day Session
Gainers
Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 87.3% to $0.6965 amid the Supreme Court overturning Roe V Wade.
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 807 companies reached new 52-week lows.
Recap: Clene Q1 Earnings
Clene (NASDAQ:CLNN) reported its Q1 earnings results on Monday, May 9, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
81 Biggest Movers From Yesterday
Gainers
Rail Vision Ltd. (NASDAQ: RVSN) shares climbed 62.4% to close at $2.16 on Wednesday after gaining around 5% on Tuesday.
Canaccord Genuity Initiates Coverage On Clene with Buy Rating, Announces Price Target of $10
Canaccord Genuity analyst Sumant Kulkarni initiates coverage on Clene (NASDAQ:CLNN) with a Buy rating and announces Price Target of $10.
Jonathan Heller Purchases 100,000 Shares Of CBL & Associates (CBL) And Other Insider Trades
When Seeking Alpha reached out to me in late 2021 to see if I would be interested in writing an article about my outlook for 2022, I appreciated this opportunity to participate in their virtual round table.
Clene Nanomedicine Presents Updated Data From Mid-Stage Amyotrophic Lateral Sclerosis Trials
Clene Inc (NASDAQ: CLNN) has announced multiple presentations of